Quarterly Results

  • Company Name :
Aurobindo Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524804
  • NSE Symbol:
  • AUROPHARMA
  • P/E(TTM):
  • 33.07
  • ISIN Demat:
  • INE406A01037
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 34.79
  • Book Value(₹):
  • 369.16
  • Market Cap(₹Cr.):
  • 66,824.13
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 2,759.89 2,822.14 2,721.43
Excise Duty 0.00 0.00 0.00
Net Sales 2,759.89 2,822.14 2,721.43
Other Operating Income 29.83 26.03 10.56
Other Income 159.52 83.77 113.98
Total Income 2,949.24 2,931.94 2,845.97
Total Expenditure 2,065.02 2,051.83 2,135.48
PBIDT 884.22 880.11 710.49
Interest 57.45 60.00 61.09
PBDT 826.77 820.11 649.40
Depreciation 71.49 70.02 93.88
Tax 174.22 187.68 155.25
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.31 3.28 -7.90
Reported Profit After Tax 581.37 559.13 408.17
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 581.37 559.13 408.17
EPS (Unit Curr.) 10.10 9.63 7.03
EPS (Adj) (Unit Curr.) 10.10 9.63 7.03
Calculated EPS (Unit Curr.) 10.01 9.63 7.03
Calculated EPS (Adj) (Unit Curr.) 10.01 9.63 7.03
Calculated EPS (Ann.) (Unit Curr.) 40.04 38.51 28.11
Calculated EPS (Adj) (Ann.) (Unit Curr.) 40.04 38.51 28.11
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 400.00 0.00
Equity 58.08 58.08 58.08
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 32.04 31.19 26.11
PBDTM(%) 29.96 29.06 23.86
PATM(%) 21.06 19.81 15.00